Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

TXG holding history

10x Genomics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXG overviewAll 13F holders of TXGFull Q2 2026 holdings

Shares (Q2 2026)
6,081
Value
$233.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of TXG by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,081$233.1K<0.1%−240−3.8%ReducedHolders
Q1 20266,321$134.2K<0.1%−29−0.5%ReducedHolders
Q4 20256,350$103.6K<0.1%+388+6.5%AddedHolders
Q3 20255,962$69.7K<0.1%−24,575−80.5%ReducedHolders
Q2 202530,537$353.6K<0.1%+24,564+411.3%AddedHolders
Q1 20255,973$52.1K<0.1%+4,532+314.5%AddedHolders
Q4 20241,441$20.7K<0.1%−5,452−79.1%ReducedHolders
Q3 20246,893$155.6K<0.1%−1,724−20.0%ReducedHolders
Q2 20248,617$167.6K<0.1%−5,275−38.0%ReducedHolders
Q1 202413,892$521.4K<0.1%−1,320−8.7%ReducedHolders
Q4 202315,212$851.3K<0.1%+2,469+19.4%AddedHolders
Q3 202312,743$525.6K<0.1%−567−4.3%ReducedHolders
Q2 202313,310$743.2K<0.1%+7,701+137.3%AddedHolders
Q1 20235,609$312.9K<0.1%+726+14.9%AddedHolders
Q4 20224,883$177.9K<0.1%−8,289−62.9%ReducedHolders
Q3 202213,172$375.0K<0.1%−1,330−9.2%ReducedHolders
Q2 202214,502$657.0K<0.1%+4,791+49.3%AddedHolders
Q1 20229,711$739.0K<0.1%+2,753+39.6%AddedHolders
Q4 20216,958$1.04M<0.1%+1,318+23.4%AddedHolders
Q3 20215,640$821.0K<0.1%+397+7.6%AddedHolders
Q2 20215,243$1.03M<0.1%+652+14.2%AddedHolders
Q1 20214,591$831.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.